CA Stock MarketDetailed Quotes

MSCL Satellos Bioscience Inc

Watchlist
  • 0.490
  • 0.0000.00%
15min DelayTrading Aug 19 10:42 ET
55.30MMarket Cap-2578P/E (TTM)

Satellos Bioscience Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-46.00%-5.66M
-499.24%-7.13M
-156.97%-14.5M
-384.06%-5.44M
-153.25%-4M
-356.99%-3.88M
43.14%-1.19M
-12.10%-5.64M
10.86%-1.12M
47.07%-1.58M
Net income from continuing operations
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
26.98%-11.32M
-100.64%-5.07M
83.13%-1.9M
Operating gains losses
-115.57%-185K
-23,666.67%-707K
-4,728.00%-1.16M
---816K
---1.53M
--1.19M
--3K
226.43%25K
----
----
Depreciation and amortization
200.00%3K
100.00%2K
-97.92%7K
-84.62%2K
-97.26%3K
-99.07%1K
-99.06%1K
103.40%337K
-88.06%13K
93.04%109.33K
Asset impairment expenditure
----
----
--0
----
----
----
----
--2.89M
----
----
Remuneration paid in stock
87.30%693K
266.17%736K
50.63%2.17M
242.97%854K
140.15%744K
-11.71%370K
-56.47%201K
48.22%1.44M
-73.07%249K
1,905.61%309.81K
Other non cashItems
----
----
----
----
----
----
----
-101.42%-140K
----
----
Change In working capital
90.27%-134K
-193.36%-253K
-62.76%369K
36.65%1.06M
517.04%416K
-259.93%-1.38M
149.67%271K
304.06%991K
356.62%775K
93.56%-99.75K
-Change in receivables
62.93%-109K
-259.18%-312K
-220.97%-323K
-356.00%-228K
575.68%3K
-184.94%-294K
761.67%196K
496.15%267K
-118.75%-50K
100.24%444
-Change in prepaid assets
-1,684.21%-301K
-569.23%-61K
-5,000.00%-102K
-669.23%-74K
-68.80%-60K
2,370.74%19K
-33.04%13K
92.80%-2K
195.68%13K
-131.99%-35.55K
-Change in payables and accrued expense
125.05%276K
93.55%120K
9.37%794K
67.61%1.36M
831.64%473K
-314.34%-1.1M
111.58%62K
285.93%726K
1,073.73%812K
95.21%-64.65K
Cash from discontinued investing activities
Operating cash flow
-46.00%-5.66M
-499.24%-7.13M
-150.75%-14.5M
-330.40%-5.44M
-153.25%-4M
-356.99%-3.88M
43.14%-1.19M
-14.89%-5.78M
-0.26%-1.26M
47.07%-1.58M
Investing cash flow
Cash flow from continuing investing activities
33,714.29%2.35M
-2.1M
-584,500.00%-17.54M
-17.52M
-350.86%-10K
-7K
0
-100.17%-3K
0
-100.13%-2.22K
Net PPE purchase and sale
42.86%-4K
---2K
-500.00%-18K
---1K
-350.86%-10K
---7K
--0
58.60%-3K
--0
---2.22K
Net investment purchase and sale
--2.36M
---2.1M
---17.52M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
33,714.29%2.35M
---2.1M
-584,500.00%-17.54M
---17.52M
-350.86%-10K
---7K
--0
-100.17%-3K
--0
-100.13%-2.22K
Financing cash flow
Cash flow from continuing financing activities
-99.97%16K
0
1,739.03%51.03M
0
-172.57%-2.02M
50.8M
2.25M
-62.76%2.78M
94.69%-7K
-61.13%2.78M
Net issuance payments of debt
--0
--0
---284K
--0
---2.53M
--1K
--2.24M
--0
--0
--0
Net common stock issuance
----
----
1,069.84%32.46M
-38,271.43%-2.69M
-3.46%2.69M
----
----
-60.80%2.78M
97.79%-7K
-60.09%2.78M
Cash dividends paid
----
----
--0
--0
----
----
----
--0
--0
----
Proceeds from stock option exercised by employees
----
----
--18.34M
--0
--0
----
----
--0
--0
----
Interest paid (cash flow from financing activities)
----
----
---93K
--0
----
----
----
--0
--0
----
Net other financing activities
----
----
--603K
--2.69M
----
----
--8K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-99.97%16K
--0
1,739.03%51.03M
--0
-172.57%-2.02M
--50.8M
--2.25M
-62.76%2.78M
94.69%-7K
-61.13%2.78M
Net cash flow
Beginning cash position
339.48%13.11M
1,046.93%22.07M
-60.50%1.92M
1,313.70%44.26M
2,424.03%48.73M
7.51%2.98M
-60.50%1.92M
578.86%4.87M
-50.09%3.13M
447.88%1.93M
Current changes in cash
-107.01%-3.29M
-969.21%-9.23M
761.58%18.99M
-1,931.59%-22.96M
-601.98%-6.03M
5,631.59%46.92M
150.71%1.06M
-169.09%-2.87M
19.29%-1.13M
-79.72%1.2M
Effect of exchange rate changes
100.51%6K
14,000.00%278K
1,611.84%1.15M
1,088.31%761K
215,824.14%1.56M
-36,890.97%-1.17M
-18.62%-2K
-5,163.16%-76K
-5,232.41%-77K
---725
End cash Position
-79.83%9.83M
339.48%13.11M
1,046.93%22.07M
1,046.93%22.07M
1,313.86%44.26M
2,424.03%48.73M
7.51%2.98M
-60.50%1.92M
-60.50%1.92M
-50.09%3.13M
Free cash from
-45.84%-5.66M
-499.41%-7.13M
-150.93%-14.52M
-330.48%-5.44M
-153.53%-4.01M
-357.81%-3.88M
43.17%-1.19M
-14.78%-5.79M
0.32%-1.26M
46.99%-1.58M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -46.00%-5.66M-499.24%-7.13M-156.97%-14.5M-384.06%-5.44M-153.25%-4M-356.99%-3.88M43.14%-1.19M-12.10%-5.64M10.86%-1.12M47.07%-1.58M
Net income from continuing operations -46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M26.98%-11.32M-100.64%-5.07M83.13%-1.9M
Operating gains losses -115.57%-185K-23,666.67%-707K-4,728.00%-1.16M---816K---1.53M--1.19M--3K226.43%25K--------
Depreciation and amortization 200.00%3K100.00%2K-97.92%7K-84.62%2K-97.26%3K-99.07%1K-99.06%1K103.40%337K-88.06%13K93.04%109.33K
Asset impairment expenditure ----------0------------------2.89M--------
Remuneration paid in stock 87.30%693K266.17%736K50.63%2.17M242.97%854K140.15%744K-11.71%370K-56.47%201K48.22%1.44M-73.07%249K1,905.61%309.81K
Other non cashItems -----------------------------101.42%-140K--------
Change In working capital 90.27%-134K-193.36%-253K-62.76%369K36.65%1.06M517.04%416K-259.93%-1.38M149.67%271K304.06%991K356.62%775K93.56%-99.75K
-Change in receivables 62.93%-109K-259.18%-312K-220.97%-323K-356.00%-228K575.68%3K-184.94%-294K761.67%196K496.15%267K-118.75%-50K100.24%444
-Change in prepaid assets -1,684.21%-301K-569.23%-61K-5,000.00%-102K-669.23%-74K-68.80%-60K2,370.74%19K-33.04%13K92.80%-2K195.68%13K-131.99%-35.55K
-Change in payables and accrued expense 125.05%276K93.55%120K9.37%794K67.61%1.36M831.64%473K-314.34%-1.1M111.58%62K285.93%726K1,073.73%812K95.21%-64.65K
Cash from discontinued investing activities
Operating cash flow -46.00%-5.66M-499.24%-7.13M-150.75%-14.5M-330.40%-5.44M-153.25%-4M-356.99%-3.88M43.14%-1.19M-14.89%-5.78M-0.26%-1.26M47.07%-1.58M
Investing cash flow
Cash flow from continuing investing activities 33,714.29%2.35M-2.1M-584,500.00%-17.54M-17.52M-350.86%-10K-7K0-100.17%-3K0-100.13%-2.22K
Net PPE purchase and sale 42.86%-4K---2K-500.00%-18K---1K-350.86%-10K---7K--058.60%-3K--0---2.22K
Net investment purchase and sale --2.36M---2.1M---17.52M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow 33,714.29%2.35M---2.1M-584,500.00%-17.54M---17.52M-350.86%-10K---7K--0-100.17%-3K--0-100.13%-2.22K
Financing cash flow
Cash flow from continuing financing activities -99.97%16K01,739.03%51.03M0-172.57%-2.02M50.8M2.25M-62.76%2.78M94.69%-7K-61.13%2.78M
Net issuance payments of debt --0--0---284K--0---2.53M--1K--2.24M--0--0--0
Net common stock issuance --------1,069.84%32.46M-38,271.43%-2.69M-3.46%2.69M---------60.80%2.78M97.79%-7K-60.09%2.78M
Cash dividends paid ----------0--0--------------0--0----
Proceeds from stock option exercised by employees ----------18.34M--0--0----------0--0----
Interest paid (cash flow from financing activities) -----------93K--0--------------0--0----
Net other financing activities ----------603K--2.69M----------8K------------
Cash from discontinued financing activities
Financing cash flow -99.97%16K--01,739.03%51.03M--0-172.57%-2.02M--50.8M--2.25M-62.76%2.78M94.69%-7K-61.13%2.78M
Net cash flow
Beginning cash position 339.48%13.11M1,046.93%22.07M-60.50%1.92M1,313.70%44.26M2,424.03%48.73M7.51%2.98M-60.50%1.92M578.86%4.87M-50.09%3.13M447.88%1.93M
Current changes in cash -107.01%-3.29M-969.21%-9.23M761.58%18.99M-1,931.59%-22.96M-601.98%-6.03M5,631.59%46.92M150.71%1.06M-169.09%-2.87M19.29%-1.13M-79.72%1.2M
Effect of exchange rate changes 100.51%6K14,000.00%278K1,611.84%1.15M1,088.31%761K215,824.14%1.56M-36,890.97%-1.17M-18.62%-2K-5,163.16%-76K-5,232.41%-77K---725
End cash Position -79.83%9.83M339.48%13.11M1,046.93%22.07M1,046.93%22.07M1,313.86%44.26M2,424.03%48.73M7.51%2.98M-60.50%1.92M-60.50%1.92M-50.09%3.13M
Free cash from -45.84%-5.66M-499.41%-7.13M-150.93%-14.52M-330.48%-5.44M-153.53%-4.01M-357.81%-3.88M43.17%-1.19M-14.78%-5.79M0.32%-1.26M46.99%-1.58M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg